| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485378 | Vaccine | 2018 | 7 Pages |
Abstract
We did not detect any biologically plausible adverse maternal outcomes following Tdap vaccination during pregnancy. This study provides further assurance that Tdap administration during pregnancy is not associated with unexpected safety risks.
Keywords
SGAICD-10-AMNHITdapPROMNMDSAHRpIPSstandard deviationUnited StatesVaccine safetyPregnancyTetanus toxoid, reduced diphtheria toxoid, and acellular pertussisSmall for gestational ageWorld Health OrganizationPertussisbody mass indexBMIidentifiersconfidence intervalMatMaternalMorthazard ratioadjusted hazard ratioPost-marketing surveillanceNew ZealandMoHMinistry of HealthUnited KingdomWHO
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jennifer B. Griffin, Lennex Yu, Donna Watson, Nikki Turner, Tony Walls, Anna S. Howe, Yannan Jiang, Helen Petousis-Harris,